米索前列醇对囊性纤维化脂肪吸收不良的影响。
Effect of misoprostol on fat malabsorption in cystic fibrosis.
作者信息
Robinson P J, Sly P D, Smith A L
机构信息
Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.
出版信息
Arch Dis Child. 1988 Sep;63(9):1081-2. doi: 10.1136/adc.63.9.1081.
Abstract
Misoprostol, a synthetic prostaglandin that is known to reduce gastric acid production and stimulate duodenal bicarbonate production, was evaluated in 22 patients with cystic fibrosis. In those patients who had greater than 10% fat malabsorption while taking pancrease the addition of misoprostol significantly reduced the degree of fat malabsorption.
摘要
米索前列醇是一种合成前列腺素，已知它能减少胃酸分泌并刺激十二指肠碳酸氢盐的分泌。对22例囊性纤维化患者进行了米索前列醇的评估。在那些服用胰酶时脂肪吸收不良超过10%的患者中，加用米索前列醇显著降低了脂肪吸收不良的程度。
相似文献
1
Effect of misoprostol on fat malabsorption in cystic fibrosis.米索前列醇对囊性纤维化脂肪吸收不良的影响。
Arch Dis Child. 1988 Sep;63(9):1081-2. doi: 10.1136/adc.63.9.1081.
2
Duodenal pH in cystic fibrosis and its relationship to fat malabsorption.囊性纤维化患者的十二指肠pH值及其与脂肪吸收不良的关系。
Dig Dis Sci. 1990 Oct;35(10):1299-304. doi: 10.1007/BF01536423.
3
Placebo-controlled trial of misoprostol in cystic fibrosis.米索前列醇治疗囊性纤维化的安慰剂对照试验。
J Pediatr Gastroenterol Nutr. 1990 Jul;11(1):37-40. doi: 10.1097/00005176-199007000-00007.
4
The use of a synthetic prostaglandin E1 analogue (misoprostol) as an adjunct to pancreatic enzyme replacement in cystic fibrosis.合成前列腺素E1类似物（米索前列醇）作为囊性纤维化中胰酶替代治疗辅助药物的应用。
Scand J Gastroenterol Suppl. 1988;143:142-7. doi: 10.3109/00365528809090235.
5
Effect of misoprostol on fat malabsorption in cystic fibrosis.米索前列醇对囊性纤维化脂肪吸收不良的影响。
Arch Dis Child. 1989 Jul;64(7):1096-7. doi: 10.1136/adc.64.7.1096-a.
6
High dose pancreatic enzymes in cystic fibrosis.囊性纤维化中的高剂量胰酶
Arch Dis Child. 1990 Mar;65(3):311-2. doi: 10.1136/adc.65.3.311.
7
Comparison of four pancreatic extracts in cystic fibrosis.四种胰腺提取物在囊性纤维化中的比较。
Arch Dis Child. 1987 Jun;62(6):564-8. doi: 10.1136/adc.62.6.564.
8
The therapeutic efficacy of misoprostol in peptic ulcer disease.米索前列醇在消化性溃疡疾病中的治疗效果。
Postgrad Med J. 1988;64 Suppl 1:60-77.
9
Misoprostol and gastroduodenal mucosal protection (cytoprotection).米索前列醇与胃十二指肠黏膜保护（细胞保护作用）
Postgrad Med J. 1988;64 Suppl 1:7-11.
10
Misoprostol: a prostaglandin for peptic ulcer.米索前列醇：一种用于治疗消化性溃疡的前列腺素。
Am Fam Physician. 1989 Aug;40(2):217-9.
引用本文的文献
1
Drug therapies for reducing gastric acidity in people with cystic fibrosis.用于降低囊性纤维化患者胃酸的药物治疗。
Cochrane Database Syst Rev. 2021 Apr 27;4(4):CD003424. doi: 10.1002/14651858.CD003424.pub5.
2
Drug therapies for reducing gastric acidity in people with cystic fibrosis.用于降低囊性纤维化患者胃酸的药物疗法。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD003424. doi: 10.1002/14651858.CD003424.pub4.
3
Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis.囊性纤维化患者鼻息肉中COX - 1和COX - 2的上调
Thorax. 2006 Jul;61(7):592-6. doi: 10.1136/thx.2004.039842. Epub 2006 Mar 3.
4
Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.奥美拉唑，一种质子泵抑制剂，可改善接受高剂量胰酶治疗的囊性纤维化患者的残余脂肪泻。
Eur J Pediatr. 2003 Nov;162(11):760-3. doi: 10.1007/s00431-003-1309-5. Epub 2003 Sep 17.
5
Control of malabsorption in cystic fibrosis.囊性纤维化中吸收不良的控制
Paediatr Drugs. 2000 May-Jun;2(3):205-22. doi: 10.2165/00128072-200002030-00005.
6
Duodenal pH in cystic fibrosis and its relationship to fat malabsorption.囊性纤维化患者的十二指肠pH值及其与脂肪吸收不良的关系。
Dig Dis Sci. 1990 Oct;35(10):1299-304. doi: 10.1007/BF01536423.
本文引用的文献
1
Gastric acid hypersecretion in cystic fibrosis.囊性纤维化中的胃酸分泌过多
J Pediatr Gastroenterol Nutr. 1982;1(4):559-65. doi: 10.1097/00005176-198212000-00019.
2
Secretin pancreozymin stimulation test and confirmation of the diagnosis of cystic fibrosis.促胰液素-缩胆囊素刺激试验与囊性纤维化诊断的确证
Gut. 1982 Sep;23(9):744-50. doi: 10.1136/gut.23.9.744.
3
Intraduodenal events in cystic fibrosis.囊性纤维化患者的十二指肠内情况
J Pediatr Gastroenterol Nutr. 1984;3 Suppl 1:S113-9. doi: 10.1097/00005176-198400031-00018.
Zotero 插件